NIH

Insulin in vials
November 18, 2015

Fighting type 2 diabetes with FGF1

The growth factor FGF1 induces the growth of new insulin-producing beta cells and may help treat type 2 diabetes.

By VUMC News and Communications
November 16, 2015

Children, heart disease, and IQ

Treatment for congenital heart disease during infancy may result in cognitive and attentional deficits during adolescence and young adulthood, Vanderbilt researchers have found.

By VUMC News and Communications
November 12, 2015

Immune system a must for kidney repair

A signaling protein that is essential for recovery from acute kidney injury works by increasing the population of tissue-repairing immune cells.

By Lorena Infante
DNA sequence visualization
November 12, 2015

Study helps clarify components of DNA ‘copy machine’

Vanderbilt investigators have generated a “parts list” for the molecular machinery that duplicates DNA each time a cell divides. The research has implications for cancer therapies that target components of this machinery.

By Leigh MacMillan
Neurons with serotonin transporters labeled with quantum dots. (Jerry Chang / Vanderbilt)
November 5, 2015

Study further links immune response, serotonin signaling

Vanderbilt University scientists are a step closer to understanding how inflammation in the body can affect mood and behavior.

By Bill Snyder
November 4, 2015

Detect and defend against pathogens

Understanding factors, such as the receptor TLR9, that detect and defend against pathogens may lead to therapeutic approaches that promote an effective immune response to treat infections.

By Leigh MacMillan
November 3, 2015

VUMC receives NIH grant to develop artificial kidney

The National Institutes of Health has awarded a four-year, $6 million grant to investigators at Vanderbilt University Medical Center (VUMC) and the University of California at San Francisco (UCSF) to develop an implantable artificial kidney.
By Paul Govern
October 30, 2015

Prenatal folic acid and asthma

The timing of folic acid-containing prescription filling during pregnancy was associated with childhood asthma, according to a new Vanderbilt study.
By Leigh MacMillan
October 29, 2015

Inflammation, obesity and diabetes

Vanderbilt study adds to the mounting role for inflammatory signaling in obesity.
By Leigh MacMillan
October 29, 2015

Compound developed at VUMC may delay Huntington’s disease

A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder.
By Bill Snyder
October 16, 2015

Healing without scarring

Drugs that inhibit the Wnt signaling pathway can regenerate injured skin and may be useful in treating fibromatosis, degenerative joint disease and cancer.
By Sanjay Mishra
October 15, 2015

Risk of death in the ICU

The irregular heart rhythm atrial fibrillation increases the risk of death in patients in the intensive care unit.
By Bill Snyder
October 15, 2015

VUSN Alzheimer’s study to explore perception of pain

Vanderbilt University School of Nursing (VUSN) has been awarded a four-year $660,633 grant from the National Institute of Health’s National Institute on Aging to study how psychophysical responses to acute experimental thermal pain differ between older adults with and without Alzheimer’s Disease (AD).
By VUMC News and Communications
1 … 61 62 63 64 65 … 104